CXCR3 and CCR5 chemokines in induced sputum from patients with COPD

被引:128
作者
Costa, Claudia [1 ]
Rufino, Rogerio [1 ]
Traves, Suzanne L. [1 ]
Lapa e Silva, Jose Roberto [2 ]
Barnes, Peter J. [1 ]
Donnelly, Louise E. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis, London SW3 6LY, England
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil
关键词
CCR5; chemokines; COPD; CXCR3; sputum;
D O I
10.1378/chest.07-0393
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: COPD is associated with increased numbers of CD4(+) and CD8(+) lymphocytes and macrophages in the small airways and lung parenchyma. The chemokines regulating T-cell recruitment into the lung are unknown but may involve CXCR3 and CCR5 chemoattractants. The aims of this study were to determine the concentrations of CXCR3 chemokines CXCL9, CXCL10, CXCL11, and the CCR5 chemokine CCL5 in induced sputum from patients with COPD, smokers, and nonsmokers, and to examine the relationship between chemokine expression, inflammatory cells, and airway obstruction. Methods: Differential cell counts were performed and concentrations of CXCL9, CXCL10, CXCL11, and CCL5 were measured in induced sputum from nonsmokers (n = 18), smokers (n = 20), and COPD patients (n = 35) using an enzyme-linked immunosorbent assay. Results: Concentrations of CXCL9, CXCL10, CXCL11, and CCL5 were significantly increased in the sputum of patients with COPD when compared with nonsmokers but not smokers without obstruction: CXCL9 (median, 14.3 pg/mL; interquartile range [IQR], 6.5 to 99.3; vs median, 1.4 pg/mL; IQR, 0 to 10.4 [p < 0.001]; vs; 8.5 pg/mL; IQR, 0 to 16.0, respectively); CXCL10 (16.9 pg/mL; IQR, 6.2 to 148.8; vs; 3.7 pg/mL; IQR, 0 to 18.8 [p < 0.05]; vs 11.3 pg/mL; IQR, 3.7 to 46.7); CXCL11 (58.1 pg/mL; IQR, 34.5 to 85.3; vs 33.5 pg/mL; IQR, 2.3.2 to 49.7 [p < 0.05]; vs 49.8 pg/mL; IQR, 32.6 to 105.6); and CCL5 (59.9 pg/mL; IQR, 57.1 to 67.8; vs 33.5 pg/mL; IQR, 31.6 to 36.9 [p < 0.001]). CCL5 in sputum from smokers was also significantly increased compared with that from nonsmokers (median, 63.0 pg/mL; IQR, 60.8 to 70.2; p < 0.001). There was a negative correlation between FEV1 percentage of predicted, FEV1/FVC ratio, and percentage of macrophages, and all the chemokines analyzed. Neutrophil numbers correlated positively with the concentrations of chemokines. Conclusions: CXCR3 chemokines and CCL5 are increased in sputum from COPD patients compared with nonsmokers, and may be important in COPD pathogenesis.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 31 条
  • [1] Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
    Annunziato, F
    Cosmi, L
    Galli, G
    Beltrame, C
    Romagnani, P
    Manetti, R
    Romagnani, S
    Maggi, E
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (05) : 691 - 699
  • [2] Induced sputum methodology: Validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individuals
    Beier, J
    Beeh, KM
    Kornmann, O
    Buhl, R
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2004, 144 (01): : 38 - 44
  • [3] Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome
    Belperio, JA
    Keane, MP
    Burdick, MD
    Lynch, JP
    Xue, YY
    Li, KW
    Ross, DJ
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 1037 - 1049
  • [4] Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease
    Bhowmik, A
    Seemungal, TAR
    Sapsford, RJ
    Devalia, JL
    Wedzicha, JA
    [J]. THORAX, 1998, 53 (11) : 953 - 956
  • [5] Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
    Cole, KE
    Strick, CA
    Paradis, TJ
    Ogborne, KT
    Loetscher, M
    Gladue, RP
    Lin, W
    Boyd, JG
    Moser, B
    Wood, DE
    Sahagan, BG
    Neote, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) : 2009 - 2021
  • [6] Inflammation of the airways and lung parenchyma in COPD
    Cosio, MG
    Majo, J
    Cosio, MG
    [J]. CHEST, 2002, 121 (05) : 160S - 165S
  • [7] Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma
    Culpitt, SV
    Rogers, DF
    Traves, SL
    Barnes, PJ
    Donnelly, LE
    [J]. RESPIRATORY MEDICINE, 2005, 99 (06) : 703 - 710
  • [8] Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
    Culpitt, SV
    Maziak, W
    Loukidis, S
    Nightingale, JA
    Matthews, JL
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) : 1635 - 1639
  • [9] Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
    Donnelly, Louise E.
    Barnes, Peter J.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (10) : 546 - 553
  • [10] Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-γ (Mig, CXCL9)
    Fulkerson, PC
    Zimmermann, N
    Brandt, EB
    Muntel, EE
    Doepker, MP
    Kavanaugh, JL
    Mishra, A
    Witte, DP
    Zhang, HW
    Farber, JM
    Yang, M
    Foster, PS
    Rothenberg, ME
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (07) : 1987 - 1992